TESTOVIRON 250MG INJ

Testoviron 250mg injection contains testosterone enanthate, a long-acting androgenic hormone formulation for testosterone replacement therapy in hypogonadal men. The 250mg intramuscular dose provides sustained serum testosterone elevation with extended dosing intervals, typically administered every 2-4 weeks depending on individual pharmacokinetics and therapeutic targets. Testosterone enanthate restores physiological hormone levels, improving sexual function, muscle mass, bone density, and overall metabolic health in testosterone-deficient patients. This injectable formulation demonstrates superior bioavailability compared to oral preparations, with predictable absorption and prolonged therapeutic duration. Testoviron is indicated for primary and secondary hypogonadism when endogenous testosterone production is inadequate. Regular monitoring of serum testosterone levels, hematocrit, prostate-specific antigen, and liver function ensures optimal dosing and safety. Potential adverse effects including polycythemia and prostate changes require periodic clinical assessment. Only use under direct medical supervision with appropriate baseline evaluation and ongoing therapeutic monitoring to achieve optimal hormonal balance and clinical outcomes.